Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Gliosarcoma 1 Glioblastoma 1

Interventions

Temozolomide 130 Radiotherapy 86 Bevacizumab 43 Radiation 31 Carmustine 29 Irinotecan 22 Erlotinib Hydrochloride 22 Magnetic Resonance Spectroscopy 21 Chemotherapy, Adjuvant 20 Surgical Procedures, Operative 15 O(6)-benzylguanine 15 Carboplatin 14 Radiotherapy, Intensity-Modulated 13 Radiotherapy, Conformal 13 sargramostim 12 Sirolimus 9 Imatinib Mesylate 9 Filgrastim 9 Drug Therapy 9 temsirolimus 8 Thalidomide 8 Sorafenib 8 Radiosurgery 8 pembrolizumab 7 motexafin gadolinium 7 aldesleukin 7 Vorinostat 7 Procarbazine 7 Gefitinib 7 Cyclophosphamide 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Gliosarcoma × Sonication × Clear all

NCT04528680 2026-04-13

SC9/ABX

Northwestern University

Phase 1/2 Active not recruiting

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡